PeptideBase
Back to Database
evidence varies by claim

OPT101

OPT101

Immune & Inflammatory

OPT101 is indexed as peptide in the PeptideBase article library. It is referenced in “OPT101 for Type 1 Diabetes: What the Small Phase 1b Trial Actually Shows”. This page groups the relevant coverage; evidence strength, safety, and clinical relevance depend on the specific claim and source.

Research status: evidence varies by claim

Deep Dives on OPT101

Start here for the plain-English articles connected to this peptide.

Research & Evidence10 min read

OPT101 for Type 1 Diabetes: What the Small Phase 1b Trial Actually Shows

What the randomized OPT101 phase 1b type 1 diabetes trial shows about short-term tolerability, Th40 biomarkers, HbA1c and C-peptide—and what remains unproven.

Read article

Quick Facts

Origin
Named peptide referenced in PeptideBase coverage
Category
Immune & Inflammatory

Research Areas

Research & Evidence

Tags

opt101peptidenamed peptide